Ligand validation:5HI6

MTX: METHOTREXATE

MTX is a Ligand Of Interest in 5HI6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HI6_MTX_A_201	66%	26%	0.129	0.933	1.08	1.87	1	9	0	0	100%	1
5HI6_MTX_B_201	57%	26%	0.146	0.921	1.1	1.87	1	7	0	0	100%	1
4QI9_MTX_B_201	86%	14%	0.097	0.965	1.94	1.91	4	12	1	0	100%	1
1RA3_MTX_A_161	97%	9%	0.058	0.974	1.61	2.84	8	23	1	0	100%	1
1U72_MTX_A_188	97%	20%	0.065	0.979	1.13	2.23	2	16	2	0	100%	1
1RG7_MTX_A_161	94%	7%	0.071	0.968	1.88	2.93	9	17	1	0	100%	1
1DDR_MTX_B_200	93%	2%	0.077	0.971	2.29	4.49	7	20	0	1	100%	1
3QXT_MTX_A_2000	92%	9%	0.065	0.954	2.19	2.23	10	18	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.